Author:
Konishi Junji,Dwamena Ben A.,Gross Milton D.,Shapiro Brahm,Misaki Takashi,Fukunaga Masao,Sisson J. C.,Oei Hong-Yoe,Jong Marion De,Krenning Eric P.
Publisher
Springer Berlin Heidelberg
Reference406 articles.
1. Abdelhamid S, Lewicka S, Vecsei P et al (1995) A new subset of mineralocorticoid hypertension with excess of 21-deoxyaldosterone and KellyVMl steroid: clinical and morphological findings. J Clin Endocrinol Metab 80:737–744
2. Adams S, Baum RP, Hertel A et al (1998 a) Comparison of metabolic and receptor imaging in recurrent medullary thyroid carcinoma with histopathological findings. Eur J Nucl Med 25:1277–1283
3. Adams S, Baum RP, Hertel A et al (1998b) Metabolic (PET) and receptor (SPET) imaging of well-and less well-differentiated tumours: comparison with the expression of the Ki-67 antigen. Nucl Med Commun 19:641–647
4. Ahlman H, Wangberg B, Jansson S et al (2000) Interventional treatment of gastrointestinal neuroendocrine tumours. Digestion 62[Suppl l]:59–68
5. Ahnert-Hilger G, Grube K, Kvols L et al (1993) Gastroentero-pancreatic neuroendocrine tumors contain a common set of synaptic vesicle proteins and aminoacid neurotransmitters. Eur J Cancer 14:1982–1984